Evidence map›Paper›PMID 42589426›Full record

ArticleInternational journal of molecular sciences2026

Morphometric Inverse Divergence Networks Combined with HYDRA Identify Parkinson's Disease Subtypes with Distinct Transcriptomic and Serum Biomarker Profiles.

Maria Giovanna Bianco, Camilla Calomino, Maria Celeste Bonacci, Maria Eugenia Caligiuri, Costanza Maria Cristiani, Luana Scaramuzzino, Jolanda Buonocore, Pier Paolo Arcuri, Aldo Quattrone, Andrea Quattrone

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maria Giovanna BiancoNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.ORCID 0000-0002-2705-8718
Camilla CalominoNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.ORCID 0009-0002-7936-8408
Maria Celeste BonacciNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.ORCID 0009-0006-8474-4905
Maria Eugenia CaligiuriNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.ORCID 0000-0002-2030-5552
Costanza Maria CristianiNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.ORCID 0000-0002-7811-2083
Luana ScaramuzzinoNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.ORCID 0000-0003-3239-3745
Jolanda BuonocoreNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.ORCID 0000-0002-3813-283X
Pier Paolo ArcuriNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.
Aldo QuattroneNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.
Andrea QuattroneNeuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.ORCID 0000-0003-2071-2083

Funding

Ministry of Universities and Research F63C22000640002 - PE0000006
6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder, yet it remains unclear whether cortical architecture can reveal biologically distinct subtypes with distinct molecular and serum biomarker signatures. Two hundred PD patients and 121 healthy controls underwent structural MRI. Subject-specific cortical similarity networks were constructed using Morphometric INverse Divergence (MIND), and subtypes were identified with HYDRA. Spatial patterns were linked to regional gene expression from the Allen Human Brain Atlas through partial least squares regression, followed by functional and cell-type enrichment analyses. Serum neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) were quantified using single-molecule array assays. No significant MIND differences emerged when PD patients were analysed as a single group. HYDRA identified two subtypes (ARI = 0.85) with divergent cortical organization that only partially overlapped with conventional motor phenotypes. Cluster 1 exhibited temporo-parietal MIND increases associated with synaptic and oligodendroglial signatures, without serum biomarker associations. Cluster 2 showed widespread fronto-cingulate MIND reductions enriched for mitochondrial, lysosomal, and proteostatic pathways, including the KEGG Parkinson's disease pathway, and these reductions correlated with higher serum NfL and GFAP. These findings reveal two biologically distinct PD subtypes with divergent molecular architecture and systemic neurodegeneration beyond conventional motor phenotyping.

Indexed as

BiomarkersParkinson DiseaseTranscriptomeAgedFemaleGlial Fibrillary Acidic ProteinHumansMagnetic Resonance ImagingMaleMiddle AgedNeurofilament ProteinsBiomarkersGFAP protein, humanGlial Fibrillary Acidic Proteinneurofilament protein LNeurofilament Proteinscortical networksdisease subtypesglial fibrillary acidic protein (GFAP)imaging transcriptomicsmorphometric inverse divergence (MIND)neurofilament light chain (NfL)Parkinson’s disease

Identifiers

PMID42589426
PMCPMC13466820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.